+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
From
Systemic Lupus Erythematosus Treatment Global Market Report 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Ankylosing Spondylitis Global Market Report 2024 - Product Thumbnail Image

Ankylosing Spondylitis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Dermatitis (Eczema) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 1197 Pages
  • Global
From
Immuno-oncology Market - Product Thumbnail Image

Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1250 Pages
  • Global
From
From
From
Loading Indicator